AMs in the National Assembly for Wales voted overwhelmingly in favour of a motion calling for a full multidisciplinary paediatric rheumatology service to be developed in Wales. Despite Cabinet Members abstaining, 27 AMs voted to support the motion, with nine abstentions and none against. There is now significant pressure on the government to take action.
Arthritis Care Wales, the British Society for Rheumatology and the National Rheumatoid Arthritis Society have been campaigning to ensure children with arthritis in Wales have access to vital services.…
Read more of this article
By Chris Graham, Chief Executive, Picker Institute Europe
What a difference a month makes. When I last wrote an introduction to the ARMA newsletter we were in the run up to an election. I’m not sure anyone expected the result to go quite the way it did. Instead of increasing their majority the Government now has no majority at all and will have to rely on the support of other parties to get their plans through. What will this mean for people with MSK conditions?
Guest blog by Liz Lingard, NHS RightCare Delivery Partner
Arthritis Research UK have created
Arthritis Care published new research to launch our Wake up to arthritis campaign during Arthritis Care Week. The report,
On Monday 8th May 2017 the Scottish Medicines Consortium (SMC) published new advice accepting the restricted use of belimumab (Benlysta) by NHS Scotland for lupus patients. This advice was published following a re-submission with evidence supplied by GlaxoSmithKline (the producers of Benlysta) and LUPUS UK on behalf of patients.
The Faculty of Sport and Exercise Medicine (FSEM) UK has published a set of key messages to guide associated organisations and colleges through the specialty of Sport and Exercise Medicine’s work and relevance to MSK Medicine.
